Annual reporting 2020 Reports, presentations and fact sheets Capital Markets Day General meeting; Shares. Recent comments by insiders confirm the thesis for Euronav. Company disclosed EPS of $1.05 on revenue of $416.7MM. Thank you. Investor Relations. Good morning and afternoon to everyone, and thanks for joining Euronav's Q1 2020 Earnings Call. ... During the earnings conference call, head of investor relations … 4.7MB Pareto Securities Shipping Conference December 2009. Euronav. Since its foundation in 1805 in Brussels, D’Ieteren has been the name of a family of entrepreneurs, that has grown into what is called today the D’Ieteren Group. 0.5MB Annual Reports. Date Title PDF; Apr 1, 2021 Scorpio Tankers Inc. 2020 Form 20-F Download pdf: Feb 18, 2021 Scorpio Tankers Inc. Q4 2020 Earnings Presentation Company profile for Euronav N.V. including key executives, insider trading, ownership, revenue and average growth rates. Find our reports. The company’s owned and operated fleet consisted of 2 ULCCs, 43 VLCCs, 26 suezmaxes (one under construction), 2 LR1s and 2 FSO vessels (both owned in 50%-50% joint venture) as of late August. Go to section Find all our reports and presentations. Investor Meeting 2009 Presentation. Listed on Euronext and the NYSE, Euronav is the world’s largest owner of crude carriers in terms of carrying capacity. Brian Gallagher-- Head of Investor Relations. … Brian Gallagher-- Head of Investor Relations, Research & Communications Thank you. It is the mission of our Group to build a family of businesses that reinvent the industries in search of excellence and meaningful impact. Share price monitor Analysts and … Get a complete overview of Ørsted's Investor relations. Euronav NV reported earnings before the opening on May 7th. View detailed EURN description & address. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. Good morning and afternoon to everyone, and thanks for joining Euronav's Q2 2020 earnings call. The Ericsson Investor Relations, website contains information about Ericsson for current stockholders, potential investors and institutional analysts, regarding stock information, earnings reports, SEC filings, upcoming events, investor news and more. IR material. Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on SINTAX™, the small intestinal axis, with systemic therapeutic effects. 20-F. 0.7MB Annual General Meeting Speech.